CVS Health Co. (NYSE:CVS) Shares Bought by Janus Henderson Group PLC

Janus Henderson Group PLC raised its stake in CVS Health Co. (NYSE:CVS - Free Report) by 370.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 760,903 shares of the pharmacy operator's stock after purchasing an additional 599,200 shares during the period. Janus Henderson Group PLC owned 0.06% of CVS Health worth $47,825,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Garland Capital Management Inc. grew its stake in shares of CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock worth $3,591,000 after acquiring an additional 160 shares in the last quarter. Sound Income Strategies LLC grew its holdings in shares of CVS Health by 7.2% in the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after acquiring an additional 162 shares in the last quarter. Plimoth Trust Co. LLC lifted its holdings in CVS Health by 0.4% during the second quarter. Plimoth Trust Co. LLC now owns 46,637 shares of the pharmacy operator's stock worth $2,754,000 after acquiring an additional 174 shares during the period. Hexagon Capital Partners LLC boosted its position in CVS Health by 3.5% in the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock worth $331,000 after purchasing an additional 178 shares during the last quarter. Finally, Pallas Capital Advisors LLC grew its stake in CVS Health by 2.5% in the 2nd quarter. Pallas Capital Advisors LLC now owns 7,458 shares of the pharmacy operator's stock valued at $447,000 after purchasing an additional 183 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of several research reports. UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. Evercore ISI lifted their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective for the company in a report on Tuesday. Mizuho cut their price target on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. Finally, Barclays decreased their price objective on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $70.50.

CVS Health Stock Performance

Shares of CVS Health stock traded down $1.59 on Friday, reaching $55.27. 9,628,385 shares of the stock were exchanged, compared to its average volume of 11,275,057. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25. The business has a 50 day moving average price of $59.39 and a two-hundred day moving average price of $58.79. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $69.55 billion, a price-to-earnings ratio of 14.03, a PEG ratio of 1.01 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company's revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the business posted $2.21 EPS. Analysts anticipate that CVS Health Co. will post 5.37 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.81%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio (DPR) is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.